11-32435327-T-G

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_ModerateBP6BS2_Supporting

The NM_024426.6(WT1):​c.34A>C​(p.Thr12Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000523 in 1,529,472 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T12A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000067 ( 0 hom., cov: 30)
Exomes 𝑓: 0.0000051 ( 0 hom. )

Consequence

WT1
NM_024426.6 missense

Scores

3
3
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 1.34

Publications

5 publications found
Variant links:
Genes affected
WT1 (HGNC:12796): (WT1 transcription factor) This gene encodes a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilms tumor. This gene exhibits complex tissue-specific and polymorphic imprinting pattern, with biallelic, and monoallelic expression from the maternal and paternal alleles in different tissues. Multiple transcript variants have been described. In several variants, there is evidence for the use of a non-AUG (CUG) translation initiation codon upstream of, and in-frame with the first AUG. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated. [provided by RefSeq, Mar 2015]
WT1-AS (HGNC:18135): (WT1 antisense RNA) This gene is located upstream of the Wilms tumor 1 (WT1) gene; these two genes are bi-directionally transcribed from the same promoter region. This gene is imprinted in kidney, with preferential expression from the paternal allele. Imprinting defects at chromosome 11p13 may contribute to tumorigenesis. [provided by RefSeq, May 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.1166344).
BP6
Variant 11-32435327-T-G is Benign according to our data. Variant chr11-32435327-T-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 406699.
BS2
High AC in GnomAdExome4 at 7 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024426.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WT1
NM_024426.6
MANE Select
c.34A>Cp.Thr12Pro
missense
Exon 1 of 10NP_077744.4
WT1
NM_024424.5
c.34A>Cp.Thr12Pro
missense
Exon 1 of 10NP_077742.3H0Y7K5
WT1
NM_001407044.1
c.34A>Cp.Thr12Pro
missense
Exon 1 of 10NP_001393973.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WT1
ENST00000452863.10
TSL:1 MANE Select
c.34A>Cp.Thr12Pro
missense
Exon 1 of 10ENSP00000415516.5P19544-7
WT1
ENST00000639563.4
TSL:1
c.34A>Cp.Thr12Pro
missense
Exon 1 of 9ENSP00000492269.3P19544-8
WT1
ENST00000332351.9
TSL:1
c.34A>Cp.Thr12Pro
missense
Exon 1 of 9ENSP00000331327.5J3KNN9

Frequencies

GnomAD3 genomes
AF:
0.00000672
AC:
1
AN:
148746
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000202
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000232
AC:
3
AN:
129334
AF XY:
0.0000424
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000288
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000507
AC:
7
AN:
1380726
Hom.:
0
Cov.:
44
AF XY:
0.00000440
AC XY:
3
AN XY:
681200
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31498
American (AMR)
AF:
0.00
AC:
0
AN:
35668
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25150
East Asian (EAS)
AF:
0.000168
AC:
6
AN:
35698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79128
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33454
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4154
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1078292
Other (OTH)
AF:
0.0000173
AC:
1
AN:
57684
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000672
AC:
1
AN:
148746
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
72374
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40084
American (AMR)
AF:
0.00
AC:
0
AN:
14772
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3444
East Asian (EAS)
AF:
0.000202
AC:
1
AN:
4956
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4756
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9944
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
298
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67552
Other (OTH)
AF:
0.00
AC:
0
AN:
2042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000756
ExAC
AF:
0.0000500
AC:
2

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
11p partial monosomy syndrome;C0950121:Drash syndrome;C0950122:Frasier syndrome;CN033288:Wilms tumor 1 (1)
-
-
1
Inborn genetic diseases (1)
-
1
-
Mesothelioma, malignant;C0950121:Drash syndrome;C0950122:Frasier syndrome;C1837026:Meacham syndrome;C3151568:Nephrotic syndrome, type 4;CN033288:Wilms tumor 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.62
CADD
Uncertain
24
DANN
Uncertain
0.99
Eigen
Benign
-0.48
Eigen_PC
Benign
-0.35
FATHMM_MKL
Uncertain
0.82
D
M_CAP
Pathogenic
0.40
D
MetaRNN
Benign
0.12
T
MetaSVM
Benign
-1.0
T
PhyloP100
1.3
PrimateAI
Uncertain
0.77
T
PROVEAN
Benign
-0.33
N
REVEL
Benign
0.072
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Vest4
0.23
MutPred
0.11
Loss of glycosylation at T7 (P = 0.016)
MVP
0.30
ClinPred
0.34
T
GERP RS
2.5
PromoterAI
0.13
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs764111950; hg19: chr11-32456873; API